| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| salirasib | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Malignant neoplasm of lung[MeSHID:D008175] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
0.05 | phase 2 | unknown |
| salirasib | gtpase nras | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Malignant neoplasm of lung[MeSHID:D008175] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
0.13 | phase 2 | unknown |
| click here to return to the previous page | ||||||||